Fact CheckerSign in

NCT00626496Recruiting

Family Study of Lymphoproliferative Disorders

Genetic Epidemiology of Lymphoproliferative Disorders

Source: ClinicalTrials.gov · Last updated 2 Nov 2026

Brief summary (registry, in English)

Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
20 Feb 2008
Start date
1 Apr 2004
Primary completion date
31 Dec 2029
Lead sponsor
Mayo Clinic
NCT number
NCT00626496

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 1 Apr 2004 to the primary completion date, 31 Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.

Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.